These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19762744)

  • 1. Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001-2005.
    Brady JE; Sun LS; Rosenberg H; Li G
    Anesth Analg; 2009 Oct; 109(4):1162-6. PubMed ID: 19762744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin.
    Lu Z; Rosenberg H; Li G
    J Clin Anesth; 2017 Jun; 39():10-14. PubMed ID: 28494877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Malignant Hyperthermia Diagnosis in New York State Ambulatory Surgery Center Discharge Records 2002 to 2011.
    Lu Z; Rosenberg H; Brady JE; Li G
    Anesth Analg; 2016 Feb; 122(2):449-53. PubMed ID: 26554462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005.
    Rosero EB; Adesanya AO; Timaran CH; Joshi GP
    Anesthesiology; 2009 Jan; 110(1):89-94. PubMed ID: 19104175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess comorbidities associated with malignant hyperthermia diagnosis in pediatric hospital discharge records.
    Li G; Brady JE; Rosenberg H; Sun LS
    Paediatr Anaesth; 2011 Sep; 21(9):958-63. PubMed ID: 21722230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
    Burkman JM; Posner KL; Domino KB
    Anesthesiology; 2007 May; 106(5):901-6; quiz 1077-8. PubMed ID: 17457120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric malignant hyperthermia: risk factors, morbidity, and mortality identified from the Nationwide Inpatient Sample and Kids' Inpatient Database.
    Salazar JH; Yang J; Shen L; Abdullah F; Kim TW
    Paediatr Anaesth; 2014 Dec; 24(12):1212-6. PubMed ID: 24974921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database.
    Sumitani M; Uchida K; Yasunaga H; Horiguchi H; Kusakabe Y; Matsuda S; Yamada Y
    Anesthesiology; 2011 Jan; 114(1):84-90. PubMed ID: 21169796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
    Flick RP; Gleich SJ; Herr MM; Wedel DJ
    Paediatr Anaesth; 2007 Jan; 17(1):22-7. PubMed ID: 17184427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
    Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR
    Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vulnerabilities of age: burns in children and older adults.
    Bessey PQ; Arons RR; Dimaggio CJ; Yurt RW
    Surgery; 2006 Oct; 140(4):705-15; discussion 715-7. PubMed ID: 17011919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data.
    DeFrances CJ; Cullen KA; Kozak LJ
    Vital Health Stat 13; 2007 Dec; (165):1-209. PubMed ID: 18350768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac arrests and deaths associated with malignant hyperthermia in north america from 1987 to 2006: a report from the north american malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesthesiology; 2008 Apr; 108(4):603-11. PubMed ID: 18362591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of malignant hyperthermia diagnoses in hospital discharge records.
    Pinyavat T; Rosenberg H; Lang BH; Wong CA; Riazi S; Brady JE; Sun LS; Li G
    Anesthesiology; 2015 Jan; 122(1):55-63. PubMed ID: 25272246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of malignant hyperthermia diagnosis in obstetric patients in the United States, 2003 to 2014.
    Guglielminotti J; Rosenberg H; Li G
    BMC Anesthesiol; 2020 Jan; 20(1):19. PubMed ID: 31959119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia.
    Bollig G; Mohr S; Raeder J
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1077-83. PubMed ID: 16095447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
    Dexter F; Epstein RH; Wachtel RE; Rosenberg H
    Anesth Analg; 2013 Jan; 116(1):118-22. PubMed ID: 23223104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of immune thrombocytopenia: analyses of administrative data.
    Segal JB; Powe NR
    J Thromb Haemost; 2006 Nov; 4(11):2377-83. PubMed ID: 16869934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of malignant hyperthermia in Denmark.
    Ording H
    Anesth Analg; 1985 Jul; 64(7):700-4. PubMed ID: 4014731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.